Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Tango Therapeutics, Inc. (TNGX)

29.95 +0.49 (+1.66%)
As of 2:22:44 PM EDT. Market Open.
Trade TNGX on Coinbase
Chart Range Bar
Loading chart for TNGX
  • Previous Close 29.46
  • Open 29.12
  • Bid 21.65 x 200
  • Ask 37.67 x 200
  • Day's Range 29.03 - 30.31
  • 52 Week Range 5.34 - 34.39
  • Volume 1,282,073
  • Avg. Volume 4,222,657
  • Market Cap (intraday) 4.876B
  • Beta (5Y Monthly) 1.13
  • PE Ratio (TTM) --
  • EPS (TTM) -0.83
  • Earnings Date (est.) Aug 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 43.82

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

www.tangotx.com

137

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 7/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TNGX
238.04%
S&P 500 (^GSPC)
10.18%

1-Year Return

TNGX
425.44%
S&P 500 (^GSPC)
20.11%

3-Year Return

TNGX
824.38%
S&P 500 (^GSPC)
70.96%

5-Year Return

TNGX
164.34%
S&P 500 (^GSPC)
73.64%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -45.51M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-40M
-20M
0
20M
40M

Analyst Insights

View More

Analyst Price Targets

24.00
43.82 Average
29.95 Current
69.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/29/2026
Analyst Canaccord Genuity
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 42 -> 46

Statistics

View More

Valuation Measures

Annual
As of 7/2/2026
  • Market Cap

    4.80B

  • Enterprise Value

    4.45B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    64.35

  • Price/Book (mrq)

    12.25

  • Enterprise Value/Revenue

    78.07

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -188.15%

  • Return on Assets (ttm)

    -20.69%

  • Return on Equity (ttm)

    -38.42%

  • Revenue (ttm)

    56.99M

  • Net Income Avi to Common (ttm)

    -107.23M

  • Diluted EPS (ttm)

    -0.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    379.84M

  • Total Debt/Equity (mrq)

    8.38%

  • Levered Free Cash Flow (ttm)

    -68.23M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

29.95 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: